MktsMarkets

BioXcel Therapeutics, Inc.
NASDAQ: BTAIKey statistics
BTAI News
Stories mentioning BTAI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 206.00 | 256.00 | 98.00 | 120.00 | 168.00 | 366.00 | 214.00 | 1,104 |
| Cost of Goods Sold | 283.00 | 32.00 | 11.00 | 107.00 | 14.00 | 831.00 | 1,170 | 62.00 |
| Gross Profit | (77.00) | 224.00 | 87.00 | 13.00 | 154.00 | (465.00) | (956.00) | 1,042 |
| Operating Expenses | ||||||||
| Research & Development | 2,955 | 6,701 | 8,740 | 10,256 | 4,554 | 5,901 | 5,101 | 8,032 |
| Sales General & Admin | 7,191 | 3,805 | 5,381 | 5,609 | 5,699 | 4,095 | 7,683 | 9,450 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (10,223) | (10,282) | (14,228) | (15,852) | (10,099) | (10,493) | (15,293) | (17,296) |
| Interest Income | 211.00 | 321.00 | 236.00 | 230.00 | 279.00 | 368.00 | 616.00 | 671.00 |
| Interest Expense | ||||||||
| Other Expense | 1,519 | 1,812 | (12,546) | 657.00 | 6,559 | 3,298 | 4,817 | 12,026 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (12,691) | (12,545) | (30,911) | (19,187) | (7,254) | (10,859) | (13,650) | (8,299) |
| Earnings Per Share (Basic) | (0.54) | (1.03) | (2.18) | (2.45) | (1.50) | (4.28) | (5.15) | (3.30) |
| Earnings Per Share (Diluted) | (0.54) | (1.03) | (2.18) | (2.45) | (1.50) | (4.28) | (5.15) | (3.30) |
| Weighted Average Shares Outstanding (Basic) | 23,571 | 12,208 | 14,196 | 7,843 | 4,834 | 2,535 | 2,649 | 2,516 |
| Weighted Average Shares Outstanding (Diluted) | 23,571 | 12,208 | 14,196 | 7,843 | 4,834 | 2,535 | 2,649 | 2,516 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BTAI
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is a stock listed on the Nasdaq Stock Market under the ticker symbol BTAI. It last traded at $0.0100 (Nov 4, 2026, 7:00 PM ET), down 12.0% on the day. That gives BioXcel Therapeutics a market capitalisation of $394.4K.
Over the past 52 weeks BTAI has traded between $0.0100 and $2.33.
Revenue for the quarter ended Mar 31, 2026 was $206.0K; a net loss of $12.7M. Revenue was up 22.6% from $168.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $206.0K | -$12.7M | -6160.7% |
| Dec 31, 2025 | $256.0K | -$12.5M | -4900.4% |
| Sep 30, 2025 | $98.0K | -$30.9M | -31541.8% |
| Jun 30, 2025 | $120.0K | -$19.2M | -15989.2% |
From BioXcel Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…